Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Virgilio Agnetti is active.

Publication


Featured researches published by Virgilio Agnetti.


European Neurology | 1978

Benign Intracranial Hypertension after Minocycline Therapy

F. Monaco; Virgilio Agnetti; Roberto Mutani

A case is reported of a young girl who developed benign intracranial hypertension, with severe bilateral papiledema and a left sixth cranial nerve palsy, after minocylcine therapy. This drug is a semisynthetic tetracycline which has proven to pass into the CSF more effectively and to have a greater lipoid solubility than the other antibiotics of the same group.


Progress in Neuro-psychopharmacology & Biological Psychiatry | 2000

Risperidone, neuroleptic malignant syndrome and probable dementia with Lewy bodies.

GianPietro Sechi; Virgilio Agnetti; Raffaella Masuri; Giovanni Andrea Deiana; Maura Pugliatti; Kai Stephan Paulus; Giulio Rosati

1. Conflicting reports are available regarding the sensitivity of patients with Dementia with Lewy bodies (DLB) to risperidone. 2. The authors studied a rare familial case of probable DLB, who developed a documented episode of neuroleptic malignant syndrome (NMS) following the exposure to risperidone. Previously, the patient had had an episode of NMS on trifluoperazine. 3. The discontinuance of risperidone, in combination with a mild increase of dopaminergic therapy, led to a complete recovery in few days. 4. In patients with DLB, a continued vigilance for extrapyramidal side effects, including NMS, would be advisable during the use of risperidone.


European Neurology | 1976

Effects of Long-Term L-Dopa Therapy on Carbohydrate Metabolism in Patients with Parkinson’s Disease

Giulio Rosati; M. Maioli; I. Aiello; A. Farris; Virgilio Agnetti

Carbohydrate metabolism and insulin secretion were investigated in 26 patients with Parkinsons disease before and during L-dopa treatment. Oral glucose tolerance tests were performed on 13 patients treated with L-dopa alone and on 7 patients treated with L-dopa combined with Carbidopa. Intravenous glucose tolerance tests were performed on additional 6 patients treated with L-dopa alone. Results indicate that chronic L-dopa administration does not modify glucose metabolism. It was observed only a significant decrease of insulin secretion after oral glucose in the early phase (15th day) of treatment with L-dopa alone. This temporary effect may be related to the peripheral conversion of L-dopa to dopamine since insulin secretion during combined therapy was normal. The mechanism by which L-dopa transiently inhibits insulin release is not clear. Perhaps the oral administration of L-dopa alone causes an alteration in some gastrointestinal functions which are involved in the handling of oral glucose.


European Neurology | 1979

Post-Convulsive Spinal Epidural Haematoma in Ankylosing Spondylitis

Virgilio Agnetti; F. Monaco; Roberto Mutani

A case of post-convulsive spinal spidural haematoma in a patient with ankylosing spondylitis is presented. As acute tetraplegia developed, surgery was performed with finding of blood clots in the extradural space from C6 to D8. Lethal evolution due to late referral to medical care stresses the need for prompt decompression of the injured spine.


Clinical Neurophysiology | 2015

Paired neurophysiological and clinical study of the brainstem at different stages of Parkinson’s Disease

E.R. de Natale; F. Ginatempo; Kai Stephan Paulus; Andrea Manca; Beniamina Mercante; Giovanni Mario Pes; Virgilio Agnetti; E. Tolu; Franca Deriu

OBJECTIVE To study brainstem function in Parkinsons Disease (PD) at different stages, through a battery of vestibular-evoked myogenic potentials (VEMPs) and compare the results with scores on clinical scales assessing the presence of symptoms linked to brainstem involvement. METHODS Cervical, masseter and ocular VEMPs were recorded in patients with early PD (n=14, disease duration 1.42±0.7years), advanced PD (n=19, disease duration 7.26±2.9years) and in 27 age-matched controls. In PD, the following clinical scales were administered: Mini-BESTest, REM sleep Behavior Disorder Screening Questionnaire (RBD-SQ), PD Sleep Scale, Epworth Sleepiness Scale and Geriatric Depression Scale. RESULTS Rate of VEMPs alterations was higher (p<0.001) in PD than controls, but similar within PD groups. However, early and advanced PD showed a different pattern of abnormalities (p=0.02), being latency delay prevalent in the former and absence in the latter. VEMP impairment correlated directly with RBD-SQ scores in both PD cohorts and inversely with Mini-BESTest scores in advanced PD. CONCLUSIONS VEMPs displayed progressive severity of alterations at different stages of PD, with remarkable correlations with presence of postural instability and RBD. SIGNIFICANCE The combined use of VEMPs may provide interesting insights into the pathophysiological mechanisms of PD at the earliest and prodromal stage of the disease.


Progress in Neuro-psychopharmacology & Biological Psychiatry | 1992

Early manifestations of dementing illness: Treatment with glycosaminoglycan polysulfate

Thomas A. Ban; Leslie C. Morey; Olaf K. Fjetland; Franco Rengo; Nicola Ferrara; Virgilio Agnetti; Marina D'onofrio; Giulio Facchini; Fernando Anzivino; Maria Alessandra Perego; Chiara Danese; Antonio Capurso; Antonio De Tommasi; Gualtiero Scardigli; Giovanni Jans; Lucilla Parnetti; Umberto Senin; B. Bergamasco

1. In a multicenter, placebo-controlled, double-blind clinical trial in 156 elderly patients with psychopathologic symptoms, glycosaminoglycan polysulfate was found to be a therapeutically effective agent in the treatment of the earliest manifestations of a dementing process. 2. Treatment with glycosaminoglycan polysulfate in the daily dosage of 600 LRU, administered on the basis of a divided dosage schedule for 24 weeks, was significantly superior to an inactive placebo on several outcome measures including the SCAG Total and factor scores (i.e., Cognitive Dysfunction, Withdrawal, Agitation/Irritability and Depression), the NOWLIS Total and Fatiguability factor scores, the MMSE, the HAM-D Total and Vegetative Symptoms factor score and the CGI Severity of Illness and Global Improvement. 3. The drug was well tolerated; vital signs and laboratory measures did not show clinically significant changes within the experimental period.


European Journal of Paediatric Neurology | 2014

Infantile-onset ascending hereditary spastic paralysis: A case report and brief literature review

Loretta Racis; Alessandra Tessa; Maura Pugliatti; Eugenia Storti; Virgilio Agnetti; Filippo M. Santorelli

BACKGROUND Infantile-onset ascending hereditary spastic paralysis (IAHSP) is a rare, early-onset autosomal recessive motor neuron disease associated with mutations in ALS2. AIM We studied a 17-year-old boy who had features of IAHSP. We also reviewed the current literature on ALS2-related syndromes. METHODS Clinical and neuroimaging studies were performed. Blood DNA analyses were combined with mRNA studies in cultured skin fibroblasts. RESULTS Like previously described cases, the patient presented with severe spastic paraparesis and showed rapid progression of paresis to the upper limbs. He also developed bulbar involvement and severe scoliosis during childhood. In blood DNA we identified a novel splice-site homozygous mutation in ALS2 (c.3836+1G > T), producing exon skipping in fibroblast mRNA and predicting premature protein truncation. CONCLUSIONS This case adds to the allelic heterogeneity of IAHSP. Review of the pertinent literature indicates a fairly homogeneous clinical picture in IAHSP that should facilitate molecular confirmation and prevention of long-term complications.


Journal of Neurology | 1989

Efficacy of carbamazepine on cerebellar tremors in patients with superior cerebellar artery syndrome

GianPietro Sechi; A. Pirisi; Virgilio Agnetti; M. Piredda; M. Zuddas; Salvatore Tanca; M. L. Piras; I. Aiello; F. Deserra; Giulio Rosati

SummaryThree patients with postural and intention cerebellar tremor caused by a cerebellar infarction in the superior cerebellar artery distribution were studied; treatment with carbamazepine resulted in marked improvement.


European Neurology | 1988

Eating Seizures and Distraction-Arousal Functions

Ganga A; GianPietro Sechi; V. Porcella; S. Traccis; Giulio Rosati; Virgilio Agnetti

Reports of epileptic seizures evoked by eating are very scarce in the literature. A review of the reported cases suggests that various mechanisms may act as triggering factors in this form of reflex e


Journal of Neurology | 1989

Upbeat nystagmus as an early sign of cerebellar astrocytoma

Sebastiano Traccis; G. Rosati; I. Aiello; M. F. Monaco; P. Loffredo; M. V. Puliga; Maria Immacolata Pirastru; Virgilio Agnetti

SummaryA boy with a left-hemispheric cerebellar astrocytoma had upbeat nystagmus exhibiting increasing-velocity slow phases. The nystagmus improved after excision of the tumour.

Collaboration


Dive into the Virgilio Agnetti's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

I. Aiello

University of Sassari

View shared research outputs
Top Co-Authors

Avatar

E. Tolu

University of Sassari

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge